Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout

Biotinylated Human HLA-A*02:01&B2M&SSX-2 (KASEKIFYV) Complex Protein (Monomer, MALS verified)

Product Sizes
25 ug
£185.00
HL2-H82ES-25UG
200 ug
£731.00
HL2-H82ES-200UG
About this Product
SKU:
HL2-H82ES
Buffer:
PBS
Conjugate:
Biotin
Extra Details:
The peptide KASEKIFYV, derived from the cancer-testis antigen SSX-2, is presented by the HLA-A*02:01/B Beta2-microglobulin (B Beta2m) complex. This peptide-MHC complex is recognized as a tumor-associated antigen and can elicit specific cytotoxic T lymphocyte (CTL) responses. Its presentation on certain tumor cells makes it a potential target for cancer immunotherapy, particularly in cancers where SSX-2 is aberrantly expressed, such as melanoma, synovial sarcoma, and some carcinomas.
Immunogen:
HLA-A*0201 & B2M & SSX-2 (KASEKIFYV)
Molecular Weight:
36.3 kDa and 11.7 kDa
Physical State:
Powder
Shipping Conditions:
Ambient
Storage Conditions:
-20[o]C
Supplier:
ACRO Biosystems
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
Biotinylated Human HLA-A*02:01&B2M&SSX-2 (KASEKIFYV) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
Immobilized Biotinylated Human HLA-A*02:01&B2M&SSX-2 (KASEKIFYV) Complex Protein (Cat. No. HL2-H82Es) at 1 ug/mL (100 uL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 ug/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.1-3 ng/mL (QC tested).
Immobilized Biotinylated Human HLA-A*02:01&B2M&SSX-2 (KASEKIFYV) Complex Protein (Cat. No. HL2-H82Es) at 1 ug/mL (100 uL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 ug/well) plate can bind Anti-B2M Antibody, Human IgG1 with a linear range of 0.1-3 ng/mL (Routinely tested).